Tumor and Systemic Immunomodulatory Effects of MEK Inhibition
Year: 2021
Type: review
Source: Current Oncology Reports
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Funder: National Cancer Institute
OpenAlex ID: W3128925460
